Search
Close this search box.
Blog

Beyond COVID-19: The New Normal In Risk-Based Monitoring (RBM) And Quality Management (RBQM)

Join our next webinar to learn first-hand how the CluePoints and Parexel partnership is driving best-in-class Risk-Based Quality Management Strategies to support clinical development. This session will focus on how early risk detection can be leveraged to detect issues across your trial and ensure operational excellence. As the COVID-19 pandemic continues, actions need to be prioritized to combat the disruption to both new and in-flight trials. We believe the challenge of identifying and actioning these critical issues in a timely manner will be the catalyst in driving the adoption of central/remote monitoring for all trials from this point on. We will share best practices for rapid use today and future adoption as we enter a new normal.

KEY DISCUSSION POINTS FOR THIS WEBINAR:

  • Enhanced data quality oversight and regulatory compliance
  • Proactive risk management to protect patient safety and support site conduct
  • Driving improved quality, accuracy, and integrity of clinical trial data
  • Increasing productivity, efficiency and cost effectiveness for sponsors

WE WILL BE RUNNING TWO SESSIONS TO ACCOMMODATE DIFFERENT TIME ZOMES:

Tuesday, May 12, 2020 at 10:30 AM EDT Registration

Wednesday, May 20 at 11:00 AM IST Registration

We hope that you can join us and please feel free to send us questions that you’d like to see covered during the event via [email protected].

Press Release
CluePoints Appoints Richard Young as Chief Strategy Officer
Press Release
CluePoints Wins Growth Award at BVA Private Equity Awards
Press Release
CluePoints Launches Medical & Safety Review (MSR) Software to Revolutionize Clinical Data Review